X-38299102-G-C
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4BS1
This summary comes from the ClinGen Evidence Repository: NM_001034853.2(RPGR):c.1099C>G (p.Pro367Ala) is a missense variant predicted to cause the substitution of proline by alanine at amino acid 367. This variant is present in gnomAD v.4.1.0 at a frequency of 0.00004278 among hemizygous individuals, with 17 variant alleles / 397,359 total alleles, which is higher than the ClinGen X-linked IRD VCEP BS1 threshold of >0.000005 (BS1). The computational predictor REVEL gives a score of 0.285, which is below the ClinGen X-linked IRD VCEP threshold of < 0.290 and predicts a non-damaging effect on RPGR function. Additionally, the splicing impact predictor SpliceAI gives a delta score of 0.02, which is below the ClinGen X-linked IRD VCEP recommended threshold of <0.1 and does not strongly predict an impact on splicing (BP4). In summary, this variant is classified as likely benign for RPGR-related retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen X-linked IRD VCEP: BS1, BP4. (VCEP specifications version 1.0.0; date of approval 05/16/2025). LINK:https://erepo.genome.network/evrepo/ui/classification/CA10385542/MONDO:0100437/106
Frequency
Consequence
NM_001034853.2 missense
Scores
Clinical Significance
Conservation
Publications
- retinitis pigmentosa 3Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- RPGR-related retinopathyInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- primary ciliary dyskinesia-retinitis pigmentosa syndromeInheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- cone-rod dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- macular degeneration, X-linked atrophicInheritance: XL Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RPGR | NM_001034853.2 | c.1099C>G | p.Pro367Ala | missense_variant | Exon 10 of 15 | ENST00000645032.1 | NP_001030025.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000268 AC: 3AN: 111979Hom.: 0 Cov.: 23 show subpopulations
GnomAD2 exomes AF: 0.0000769 AC: 14AN: 182000 AF XY: 0.0000901 show subpopulations
GnomAD4 exome AF: 0.0000364 AC: 40AN: 1097816Hom.: 0 Cov.: 31 AF XY: 0.0000413 AC XY: 15AN XY: 363214 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000268 AC: 3AN: 111979Hom.: 0 Cov.: 23 AF XY: 0.0000586 AC XY: 2AN XY: 34145 show subpopulations
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Uncertain:1Benign:1
The p.P367A variant (also known as c.1099C>G), located in coding exon 10 of the RPGR gene, results from a C to G substitution at nucleotide position 1099. The proline at codon 367 is replaced by alanine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
- -
Retinal dystrophy Uncertain:1
- -
not provided Benign:1
RPGR: BP4, BS1 -
RPGR-related retinopathy Benign:1
NM_001034853.2(RPGR):c.1099C>G (p.Pro367Ala) is a missense variant predicted to cause the substitution of proline by alanine at amino acid 367. This variant is present in gnomAD v.4.1.0 at a frequency of 0.00004278 among hemizygous individuals, with 17 variant alleles / 397,359 total alleles, which is higher than the ClinGen X-linked IRD VCEP BS1 threshold of >0.000005 (BS1). The computational predictor REVEL gives a score of 0.285, which is below the ClinGen X-linked IRD VCEP threshold of < 0.290 and predicts a non-damaging effect on RPGR function. Additionally, the splicing impact predictor SpliceAI gives a delta score of 0.02, which is below the ClinGen X-linked IRD VCEP recommended threshold of <0.1 and does not strongly predict an impact on splicing (BP4). In summary, this variant is classified as likely benign for RPGR-related retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen X-linked IRD VCEP: BS1, BP4. (VCEP specifications version 1.0.0; date of approval 05/16/2025). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at